best performing us mid cap between 1 january 2026 to 7 january 2026

Regencell Bioscience (RGC) had the highest return between January 1, 2026 and January 7, 2026 by a mid-cap US stock, returning 139.9%.

ASSETDATE% RETURN
Regencell Bioscience (RGC)
1/1/2026 - 1/7/2026
139.93%
Evolution Metals & Technologies Corp Common Stock (EMAT)
1/1/2026 - 1/7/2026
71.64%
AXT (AXTI)
1/1/2026 - 1/7/2026
40.17%
USA Rare Earth (USAR)
1/1/2026 - 1/7/2026
39.98%
Erasca (ERAS)
1/1/2026 - 1/7/2026
39.35%
Navitas Semiconductor (NVTS)
1/1/2026 - 1/7/2026
37.47%
Strive (ASST)
1/1/2026 - 1/7/2026
34.37%
Nuscale Power (SMR)
1/1/2026 - 1/7/2026
33.72%
Tango Therapeutics (TNGX)
1/1/2026 - 1/7/2026
33.22%
Oklo (OKLO)
1/1/2026 - 1/7/2026
31.91%
Figure Technology Solutions, Inc Class A Common Stock (FIGR)
1/1/2026 - 1/7/2026
31.03%
Centrus Energy (LEU)
1/1/2026 - 1/7/2026
30.31%
Energy Fuels (UUUU)
1/1/2026 - 1/7/2026
29.26%
AeroVironment (AVAV)
1/1/2026 - 1/7/2026
28.19%
Silicon Motion Technology (SIMO)
1/1/2026 - 1/7/2026
28.11%
Ultra Clean (UCTT)
1/1/2026 - 1/7/2026
27.93%
Redwire (RDW)
1/1/2026 - 1/7/2026
24.12%
Karman (KRMN)
1/1/2026 - 1/7/2026
23.56%
Ichor (ICHR)
1/1/2026 - 1/7/2026
23.03%
Innodata (INOD)
1/1/2026 - 1/7/2026
22.03%
Denison Mines (DNN)
1/1/2026 - 1/7/2026
21.53%
MP Materials (MP)
1/1/2026 - 1/7/2026
21.41%
Warby Parker (WRBY)
1/1/2026 - 1/7/2026
21.39%
Hycroft Mining (HYMC)
1/1/2026 - 1/7/2026
21.26%
Abcellera Biologics  (ABCL)
1/1/2026 - 1/7/2026
20.76%
Mid-cap stocks are treated as having a market cap between $2B and $10B.